Now that Pliant Therapeutics Inc.’s volume has hit 3.17 million, investors get a glimpse of its size.

Pliant Therapeutics Inc. (NASDAQ: PLRX) kicked off on January 24, 2023, at the price of $31.07, up 8.78% from the previous trading day. During the day, the shares moved up to $33.29 and dropped to $30.42 before settling in for the closing price of $30.28. Over the past 52 weeks, PLRX has traded in a range of $3.96-$36.50.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


While this was happening, its average annual earnings per share was recorded -39.40%. With a float of $45.52 million, this company’s outstanding shares have now reached $46.80 million.

In an organization with 91 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +57.69, operating margin of -1288.10, and the pretax margin is -1284.51.

Pliant Therapeutics Inc. (PLRX) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Pliant Therapeutics Inc. is 0.90%, while institutional ownership is 94.20%. The most recent insider transaction that took place on Jan 09, was worth 95,829. In this transaction President and CEO of this company sold 5,000 shares at a rate of $19.17, taking the stock ownership to the 93,812 shares. Before that another transaction happened on Jan 06, when Company’s President and CEO sold 15,000 for $19.04, making the entire transaction worth $285,584. This insider now owns 93,812 shares in total.

Pliant Therapeutics Inc. (PLRX) Performance Highlights and Predictions

In the latest quarterly report, which was put into the public domain on 6/29/2022, the organization reported -$0.82 earnings per share (EPS), lower than consensus estimate (set at -$0.81) by -$0.01. This company achieved a net margin of -1284.51 while generating a return on equity of -40.35. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.74 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -39.40% per share during the next fiscal year.

Pliant Therapeutics Inc. (NASDAQ: PLRX) Trading Performance Indicators

Take a look at Pliant Therapeutics Inc.’s (PLRX) current performance indicators. Last quarter, stock had a quick ratio of 14.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 161.34.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.93, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -3.00 in one year’s time.

Technical Analysis of Pliant Therapeutics Inc. (PLRX)

Let’s dig in a bit further. During the last 5-days, its volume was 3.51 million. That was better than the volume of 1.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 73.68%. Additionally, its Average True Range was 2.12.

During the past 100 days, Pliant Therapeutics Inc.’s (PLRX) raw stochastic average was set at 82.27%, which indicates a significant increase from 80.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.91% in the past 14 days, which was higher than the 73.23% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $20.09, while its 200-day Moving Average is $16.22. However, in the short run, Pliant Therapeutics Inc.’s stock first resistance to watch stands at $34.01. Second resistance stands at $35.09. The third major resistance level sits at $36.88. If the price goes on to break the first support level at $31.14, it is likely to go to the next support level at $29.35. Assuming the price breaks the second support level, the third support level stands at $28.27.

Pliant Therapeutics Inc. (NASDAQ: PLRX) Key Stats

The company with the Market Capitalisation of 1.56 billion has total of 48,759K Shares Outstanding. Its annual sales at the moment are 7,570 K in contrast with the sum of -97,260 K annual income. Company’s last quarter sales were recorded 1,480 K and last quarter income was -30,620 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

NextGen Healthcare Inc. (NXGN) distance from 200-day Simple Moving Average is $18.41: Right on the Precipice

NextGen Healthcare Inc. (NASDAQ: NXGN) open the trading on January 26, 2023, with great promise as it jumped 2.82% to $18.58. During the day,...

TC Energy Corporation (TRP) EPS is poised to hit 1.09 next quarter: How Investors Can Make It Count the Most?

Witnessing the stock’s movement on the chart, on Thursday, TC Energy Corporation (NYSE: TRP) set off with pace as it heaved 0.86% to $43.19,...

Organon & Co. (OGN) PE Ratio stood at $7.65: Odds are Looking Good After Recent Activity

Organon & Co. (NYSE: OGN) flaunted slowness of -1.04% at $30.32, as the Stock market unbolted on January 26, 2023. During the day, the...


Please enter your comment!
Please enter your name here